10-Q 1 gtbif-20240930.htm 10-Q 10-Q
false0001795139Q3--12-310001795139gtbif:DharmaPharmaceuticalsLlcMembersrt:MaximumMember2024-01-012024-09-300001795139us-gaap:RetainedEarningsMember2023-09-300001795139gtbif:SubordinateVotingSharesMembergtbif:ShareCapitalMember2023-12-310001795139us-gaap:FairValueInputsLevel3Member2024-06-3000017951392024-07-012024-09-300001795139gtbif:FloridaAndLllinoisMember2024-01-012024-09-300001795139us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel1Member2024-07-012024-09-300001795139us-gaap:CostOfSalesMember2023-07-012023-09-300001795139gtbif:AcquiredDebtMember2024-09-300001795139us-gaap:NoncontrollingInterestMember2024-06-300001795139gtbif:SubordinateVotingSharesMember2024-11-010001795139us-gaap:FairValueInputsLevel1Member2023-07-012023-09-300001795139us-gaap:FairValueInputsLevel3Member2023-07-012023-09-300001795139us-gaap:RetainedEarningsMember2024-07-012024-09-300001795139us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel1Member2022-12-310001795139gtbif:EquityClassifiedWarrantMember2024-01-012024-09-3000017951392017-01-012017-12-3100017951392023-01-012023-12-310001795139gtbif:SyndicatedCreditFacilitySeptemberElevenTwoThousandTwentyFourMember2024-09-300001795139gtbif:FinancialInstrumentsMember2023-12-310001795139gtbif:ContributedSurplusMember2024-01-012024-09-300001795139gtbif:DharmaPharmaceuticalsLlcMembergtbif:SubordinateVotingSharesMember2024-02-152024-02-150001795139gtbif:WarwickNewYorkMortgageNoteMember2024-09-042024-09-040001795139gtbif:DharmaPharmaceuticalsLlcMember2024-02-152024-02-150001795139us-gaap:WarrantMember2024-07-012024-09-300001795139gtbif:LiabilityClassifiedWarrantMember2023-01-012023-12-310001795139gtbif:ContributedSurplusMember2023-01-012023-09-300001795139gtbif:SuperVotingSharesMembergtbif:ConversionOfSuperVotingSharesMember2024-01-012024-09-300001795139gtbif:PrivatePlacementRefinancingWarrants1Membergtbif:EquityClassifiedWarrantMember2023-12-310001795139us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember2023-12-310001795139gtbif:FinancialInstrumentsMember2024-09-300001795139us-gaap:EquityMethodInvestmentsMember2023-07-012023-09-300001795139us-gaap:RetainedEarningsMember2023-07-012023-09-300001795139us-gaap:FairValueInputsLevel3Membergtbif:FinancialInstrumentsMember2023-12-3100017951392023-09-300001795139us-gaap:EquityMethodInvestmentsMember2024-07-012024-09-300001795139srt:MaximumMember2024-01-012024-09-300001795139us-gaap:MeasurementInputRiskFreeInterestRateMembergtbif:EquityClassifiedWarrantMembergtbif:DispensaryMortgageWarrantsMember2024-09-300001795139us-gaap:FairValueInputsLevel1Member2024-09-300001795139us-gaap:NotesReceivableMember2024-01-090001795139gtbif:SyndicatedCreditFacilitySeptemberElevenTwoThousandTwentyFourMember2024-09-110001795139us-gaap:OtherIntangibleAssetsMember2024-09-300001795139gtbif:PrivatePlacementRefinancingWarrantsMembergtbif:EquityClassifiedWarrantMemberus-gaap:MeasurementInputExpectedTermMember2024-01-012024-09-300001795139gtbif:ContributedSurplusMember2024-09-300001795139gtbif:SuperVotingSharesMember2024-09-300001795139us-gaap:NotesReceivableMember2024-01-092024-01-090001795139us-gaap:FairValueInputsLevel3Memberus-gaap:NotesReceivableMember2024-09-300001795139gtbif:MortgageNotesMember2024-09-300001795139us-gaap:FairValueInputsLevel3Memberus-gaap:NotesReceivableMembersrt:MinimumMember2024-01-012024-09-300001795139us-gaap:FairValueInputsLevel3Memberus-gaap:NotesReceivableMember2023-06-300001795139gtbif:DeferredShareIssuanceMember2024-09-300001795139us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel1Member2023-09-300001795139us-gaap:AssetUnderConstructionMember2024-09-300001795139gtbif:LiabilityClassifiedWarrantMember2023-12-3100017951392019-01-012019-12-310001795139us-gaap:FairValueInputsLevel3Memberus-gaap:NotesReceivableMember2023-01-012023-09-300001795139us-gaap:NoncontrollingInterestMember2023-12-310001795139gtbif:ContributedSurplusMember2024-06-300001795139us-gaap:FairValueInputsLevel2Membergtbif:FinancialInstrumentsMember2023-12-3100017951392017-12-310001795139us-gaap:FairValueInputsLevel3Member2024-07-012024-09-300001795139us-gaap:MeasurementInputRiskFreeInterestRateMembersrt:MinimumMembergtbif:LiabilityClassifiedWarrantMember2023-12-310001795139gtbif:AdditionalModificationWarrantsMembergtbif:LiabilityClassifiedWarrantMember2023-12-310001795139gtbif:MultipleVotingSharesMember2023-01-012023-12-310001795139us-gaap:RetainedEarningsMember2024-01-012024-09-300001795139us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300001795139us-gaap:CommonStockMember2023-06-300001795139us-gaap:OperatingSegmentsMembergtbif:RetailSegmentMember2023-01-012023-09-300001795139us-gaap:OperatingSegmentsMembergtbif:RetailSegmentMember2023-07-012023-09-300001795139us-gaap:MeasurementInputRiskFreeInterestRateMembergtbif:PrivatePlacementRefinancingWarrantsMembergtbif:EquityClassifiedWarrantMember2024-09-300001795139us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel1Member2023-01-012023-09-300001795139gtbif:SubordinateVotingSharesMember2023-12-310001795139gtbif:LiabilityClassifiedWarrantMembergtbif:PrivatePlacementFinancingWarrantsMember2023-12-310001795139us-gaap:LandImprovementsMember2024-09-300001795139us-gaap:FairValueInputsLevel1Member2023-12-310001795139srt:MinimumMember2023-01-012023-12-310001795139us-gaap:MeasurementInputPriceVolatilityMembergtbif:LiabilityClassifiedWarrantMembersrt:MaximumMember2024-09-300001795139gtbif:PrivatePlacementDebtAprilThirtyTwoThousandTwentyOneMember2024-09-300001795139gtbif:MultipleVotingSharesMember2023-12-310001795139gtbif:PrivatePlacementRefinancingWarrants1Membergtbif:EquityClassifiedWarrantMember2024-09-300001795139gtbif:RetailSegmentMember2024-09-300001795139us-gaap:EquityMethodInvestmentsMember2023-01-012023-09-300001795139us-gaap:CommonStockMember2022-12-310001795139us-gaap:MeasurementInputPriceVolatilityMembergtbif:LiabilityClassifiedWarrantMembersrt:MaximumMember2023-12-310001795139gtbif:WarwickNewYorkMortgageNoteMember2024-09-040001795139gtbif:SubordinateVotingSharesMember2024-09-300001795139us-gaap:FairValueInputsLevel3Memberus-gaap:NotesReceivableMember2024-06-300001795139us-gaap:WarrantMember2024-01-012024-09-300001795139gtbif:CannabisCompaniesMember2024-09-300001795139gtbif:SubordinateVotingSharesMembergtbif:ShareCapitalMember2024-01-012024-09-300001795139us-gaap:RestrictedStockUnitsRSUMember2024-07-012024-09-300001795139us-gaap:FairValueInputsLevel3Memberus-gaap:NotesReceivableMember2023-07-012023-09-300001795139us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001795139us-gaap:CustomerRelationshipsMember2024-09-300001795139us-gaap:OperatingSegmentsMembergtbif:ConsumerPackagedGoodsSegmentMember2024-07-012024-09-300001795139gtbif:FloridaAndLllinoisMembersrt:MaximumMember2024-09-300001795139gtbif:PrivatePlacementRefinancingWarrants1Membergtbif:EquityClassifiedWarrantMember2024-01-012024-09-300001795139gtbif:ConversionOfMultipleVotingSharesMembergtbif:MultipleVotingSharesMember2024-01-012024-09-300001795139us-gaap:FairValueInputsLevel1Member2024-06-300001795139us-gaap:CommonStockMember2023-01-012023-09-300001795139us-gaap:RetainedEarningsMember2024-06-300001795139gtbif:MortgageNotesMembersrt:MaximumMember2023-12-310001795139us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001795139gtbif:SuperVotingSharesMember2023-12-310001795139us-gaap:FairValueInputsLevel3Member2023-06-300001795139us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001795139gtbif:SuperVotingSharesMembergtbif:ShareCapitalMember2024-01-012024-09-300001795139gtbif:ThirdPartyMember2024-09-300001795139us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel1Member2023-12-310001795139gtbif:EquityClassifiedWarrantMembergtbif:DispensaryMortgageWarrantsMember2024-09-300001795139gtbif:AdditionalModificationWarrantsMembergtbif:LiabilityClassifiedWarrantMember2023-01-012023-12-310001795139us-gaap:RetainedEarningsMember2024-09-300001795139us-gaap:CostOfSalesMember2023-01-012023-09-300001795139us-gaap:FairValueInputsLevel3Memberus-gaap:NotesReceivableMember2023-09-300001795139gtbif:AcquiredDebtMember2023-12-310001795139us-gaap:OperatingSegmentsMembergtbif:ConsumerPackagedGoodsSegmentMember2024-09-300001795139gtbif:MultipleConvertedVotingSharesMember2024-01-012024-09-300001795139us-gaap:PendingLitigationMember2023-01-012023-12-310001795139gtbif:LicensesAndPermitsMember2023-12-310001795139us-gaap:MeasurementInputPriceVolatilityMembergtbif:PrivatePlacementRefinancingWarrantsMembergtbif:EquityClassifiedWarrantMember2024-09-300001795139us-gaap:NotesReceivableMember2023-01-012023-09-300001795139us-gaap:RetainedEarningsMember2022-12-310001795139us-gaap:NoncontrollingInterestMember2023-07-012023-09-300001795139gtbif:ConsumerPackagedGoodsSegmentMember2023-12-310001795139us-gaap:MeasurementInputPriceVolatilityMembersrt:MinimumMembergtbif:LiabilityClassifiedWarrantMember2024-09-3000017951392023-01-012023-09-300001795139us-gaap:OperatingSegmentsMembergtbif:ConsumerPackagedGoodsSegmentMember2023-01-012023-09-300001795139us-gaap:MeasurementInputPriceVolatilityMembergtbif:EquityClassifiedWarrantMembergtbif:DispensaryMortgageWarrantsMember2024-09-300001795139us-gaap:WarrantMember2023-01-012023-09-300001795139gtbif:DeferredShareIssuanceMember2023-06-3000017951392024-01-012024-09-300001795139gtbif:DeferredShareIssuanceMember2023-12-310001795139us-gaap:EmployeeStockOptionMember2024-07-012024-09-300001795139gtbif:SuperVotingSharesMember2024-11-010001795139gtbif:RepurchaseOfSubordinateVotingSharesMember2024-09-130001795139gtbif:DeferredShareIssuanceMember2023-01-012023-09-300001795139us-gaap:FairValueInputsLevel3Member2024-01-012024-09-300001795139gtbif:SyndicatedCreditFacilitySeptemberElevenTwoThousandTwentyFourMember2024-09-112024-09-110001795139gtbif:MortgageNotesMembersrt:MinimumMember2024-01-012024-09-300001795139us-gaap:OperatingSegmentsMembergtbif:IntersegmentEliminationsAndCorporateMember2024-07-012024-09-300001795139us-gaap:FairValueInputsLevel3Member2024-09-300001795139gtbif:ConsumerPackagedGoodsSegmentMember2024-09-300001795139us-gaap:NoncontrollingInterestMember2022-12-310001795139gtbif:CannabisCompaniesMember2023-12-310001795139us-gaap:FairValueInputsLevel1Membergtbif:FinancialInstrumentsMember2024-09-300001795139us-gaap:OperatingSegmentsMembergtbif:RetailSegmentMember2023-12-310001795139us-gaap:AssetUnderConstructionMember2023-12-310001795139us-gaap:EmployeeStockOptionMember2024-01-012024-09-300001795139srt:MinimumMembergtbif:FloridaAndLllinoisMember2024-09-3000017951392022-12-310001795139gtbif:RepurchaseOfSubordinateVotingSharesMember2024-09-300001795139us-gaap:OperatingSegmentsMembergtbif:RetailSegmentMember2024-01-012024-09-300001795139gtbif:NonCompetitionAgreementMember2024-09-300001795139gtbif:FloridaAndLllinoisMember2023-07-012023-09-300001795139gtbif:LiabilityClassifiedWarrantMembersrt:MaximumMemberus-gaap:MeasurementInputExpectedTermMember2023-01-012023-12-310001795139gtbif:DharmaPharmaceuticalsLlcMember2024-02-092024-02-090001795139us-gaap:OperatingSegmentsMembergtbif:IntersegmentEliminationsAndCorporateMember2024-01-012024-09-300001795139gtbif:LiabilityClassifiedWarrantMembergtbif:PrivatePlacementFinancingWarrantsMember2023-01-012023-12-310001795139us-gaap:CostOfSalesMember2024-07-012024-09-300001795139us-gaap:FairValueInputsLevel3Member2023-01-012023-09-300001795139us-gaap:LeaseholdImprovementsMember2023-12-310001795139us-gaap:EmployeeStockOptionMember2023-07-012023-09-300001795139gtbif:LicensesAndPermitsMember2024-09-300001795139srt:MinimumMembergtbif:LiabilityClassifiedWarrantMemberus-gaap:MeasurementInputExpectedTermMember2023-01-012023-12-310001795139us-gaap:CommonStockMember2024-07-012024-09-300001795139gtbif:ContributedSurplusMember2022-12-310001795139gtbif:PrivatePlacementDebtAprilThirtyTwoThousandTwentyOneMember2023-12-310001795139gtbif:DeferredShareIssuanceMember2023-09-300001795139us-gaap:CommonStockMember2023-09-300001795139us-gaap:EmployeeStockOptionMember2024-07-012024-09-300001795139gtbif:MultipleVotingSharesMembergtbif:ShareCapitalMember2024-09-300001795139gtbif:PrivatePlacementRefinancingWarrants1Memberus-gaap:MeasurementInputRiskFreeInterestRateMembergtbif:EquityClassifiedWarrantMember2024-09-300001795139us-gaap:FairValueInputsLevel1Member2023-01-012023-09-300001795139srt:MinimumMember2024-01-012024-09-300001795139us-gaap:CommonStockMember2023-07-012023-09-300001795139gtbif:PrivatePlacementRefinancingWarrantsMembergtbif:EquityClassifiedWarrantMember2024-09-300001795139us-gaap:FurnitureAndFixturesMember2023-12-310001795139us-gaap:MeasurementInputRiskFreeInterestRateMembersrt:MinimumMembergtbif:LiabilityClassifiedWarrantMember2024-09-300001795139gtbif:EquityClassifiedWarrantMembergtbif:DispensaryMortgageWarrantsMember2023-12-310001795139us-gaap:FairValueInputsLevel1Member2023-06-3000017951392023-12-310001795139us-gaap:NoncontrollingInterestMember2023-09-3000017951392023-07-012023-09-300001795139gtbif:EquityClassifiedWarrantMember2024-09-300001795139us-gaap:FairValueInputsLevel3Member2022-12-310001795139us-gaap:OperatingSegmentsMembergtbif:IntersegmentEliminationsAndCorporateMember2023-07-012023-09-300001795139us-gaap:NotesReceivableMember2024-01-012024-09-300001795139gtbif:SyndicatedCreditFacilitySeptemberElevenTwoThousandTwentyFourMember2023-12-310001795139gtbif:RetailSegmentMember2023-12-310001795139us-gaap:EmployeeStockOptionMember2023-07-012023-09-300001795139us-gaap:OperatingSegmentsMembergtbif:ConsumerPackagedGoodsSegmentMember2024-01-012024-09-300001795139gtbif:ContributedSurplusMember2023-07-012023-09-300001795139us-gaap:NoncontrollingInterestMember2023-01-012023-09-300001795139us-gaap:SubsequentEventMembergtbif:AgrifyCorporationMember2024-11-052024-11-050001795139gtbif:FloridaAndLllinoisMember2023-01-012023-09-300001795139us-gaap:TradeNamesMember2023-12-3100017951392024-06-300001795139gtbif:EquityClassifiedWarrantMembergtbif:DispensaryMortgageWarrantsMember2024-01-012024-09-300001795139gtbif:MortgageNotesMembersrt:MinimumMember2024-09-300001795139gtbif:LiabilityClassifiedWarrantMember2024-09-300001795139gtbif:NonCompetitionAgreementMember2023-12-310001795139gtbif:MortgageNotesMembersrt:MaximumMember2023-01-012023-12-310001795139us-gaap:CommonStockMember2024-09-300001795139gtbif:MultipleVotingSharesMember2024-09-300001795139gtbif:ContributedSurplusMember2023-09-300001795139srt:MaximumMember2023-01-012023-12-3100017951392019-12-310001795139us-gaap:FairValueInputsLevel1Member2023-09-300001795139gtbif:AdditionalModificationWarrantsMembergtbif:LiabilityClassifiedWarrantMember2024-09-300001795139gtbif:DeferredShareIssuanceMember2024-06-300001795139gtbif:ModificationWarrantsMembergtbif:LiabilityClassifiedWarrantMember2023-01-012023-12-310001795139gtbif:FloridaAndLllinoisMember2024-07-012024-09-300001795139us-gaap:RetainedEarningsMember2023-01-012023-09-300001795139us-gaap:CommonStockMember2023-12-310001795139us-gaap:CommonStockMember2024-01-012024-09-300001795139us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel1Member2024-09-300001795139us-gaap:FurnitureAndFixturesMember2024-09-300001795139us-gaap:FairValueInputsLevel3Membergtbif:FinancialInstrumentsMember2024-09-300001795139us-gaap:OperatingSegmentsMembergtbif:RetailSegmentMember2024-09-300001795139us-gaap:NotesReceivableMember2024-07-012024-09-300001795139gtbif:SuperVotingSharesMember2024-01-012024-09-300001795139gtbif:SuperVotingSharesMembergtbif:ShareCapitalMember2024-09-300001795139us-gaap:OtherIntangibleAssetsMember2023-12-310001795139us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember2024-09-300001795139gtbif:MultipleConvertedVotingSharesMember2024-11-010001795139gtbif:ContributedSurplusMember2023-06-300001795139gtbif:SuperVotingSharesMember2023-01-012023-12-310001795139us-gaap:LandMember2023-12-310001795139gtbif:LiabilityClassifiedWarrantMembersrt:MaximumMemberus-gaap:MeasurementInputExpectedTermMember2024-01-012024-09-300001795139us-gaap:FairValueInputsLevel3Memberus-gaap:NotesReceivableMembersrt:MaximumMember2024-01-012024-09-300001795139us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001795139us-gaap:OperatingSegmentsMembergtbif:ConsumerPackagedGoodsSegmentMember2023-07-012023-09-300001795139gtbif:ModificationWarrantsMembergtbif:LiabilityClassifiedWarrantMember2023-12-310001795139us-gaap:NoncontrollingInterestMember2024-01-012024-09-300001795139us-gaap:OperatingSegmentsMembergtbif:IntersegmentEliminationsAndCorporateMember2023-01-012023-09-300001795139gtbif:LiabilityClassifiedWarrantMembergtbif:PrivatePlacementFinancingWarrantsMember2024-09-300001795139gtbif:GtiiStockAndIncentivePlanMembergtbif:SubordinateVotingSharesMember2018-06-012018-06-010001795139gtbif:SubordinateVotingSharesMember2024-01-012024-09-300001795139us-gaap:MeasurementInputPriceVolatilityMembersrt:MinimumMembergtbif:LiabilityClassifiedWarrantMember2023-12-310001795139us-gaap:FairValueInputsLevel3Memberus-gaap:NotesReceivableMember2024-01-012024-09-300001795139us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel1Member2024-01-012024-09-300001795139gtbif:ContributedSurplusMember2023-12-310001795139gtbif:PrivatePlacementRefinancingWarrantsMembergtbif:EquityClassifiedWarrantMember2023-12-310001795139gtbif:PrivatePlacementRefinancingWarrantsMembergtbif:EquityClassifiedWarrantMember2024-01-012024-09-300001795139us-gaap:OperatingSegmentsMembergtbif:RetailSegmentMember2024-07-012024-09-300001795139gtbif:SubordinateVotingSharesMember2023-01-012023-12-3100017951392024-09-300001795139gtbif:ConstructionCommitmentsMember2024-09-3000017951392023-06-300001795139gtbif:DispensaryMortgageWarrantsMembergtbif:EquityClassifiedWarrantMemberus-gaap:MeasurementInputExpectedTermMember2024-01-012024-09-300001795139us-gaap:NoncontrollingInterestMember2023-06-300001795139gtbif:PrivatePlacementRefinancingWarrants1Memberus-gaap:MeasurementInputPriceVolatilityMembergtbif:EquityClassifiedWarrantMember2024-09-300001795139gtbif:LiabilityClassifiedWarrantMember2024-01-012024-09-300001795139us-gaap:LandImprovementsMember2023-12-310001795139us-gaap:CustomerRelationshipsMember2023-12-310001795139us-gaap:FairValueInputsLevel1Membergtbif:FinancialInstrumentsMember2023-12-310001795139gtbif:ShareCapitalMembergtbif:MultipleVotingSharesMember2024-01-012024-09-300001795139us-gaap:OperatingSegmentsMembergtbif:ConsumerPackagedGoodsSegmentMember2023-12-310001795139us-gaap:LandMember2024-09-300001795139us-gaap:FairValueInputsLevel3Memberus-gaap:NotesReceivableMember2023-12-310001795139us-gaap:FairValueInputsLevel3Memberus-gaap:NotesReceivableMember2022-12-310001795139us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel1Member2023-07-012023-09-300001795139gtbif:MortgageNotesMember2023-12-310001795139us-gaap:CostOfSalesMember2024-01-012024-09-300001795139us-gaap:NoncontrollingInterestMember2024-07-012024-09-300001795139us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel1Member2024-06-300001795139us-gaap:EquityMethodInvestmentsMember2024-01-012024-09-300001795139us-gaap:SubsequentEventMembergtbif:AgrifyCorporationMember2024-11-050001795139us-gaap:BuildingImprovementsMember2023-12-310001795139gtbif:PrivatePlacementRefinancingWarrants1Membergtbif:EquityClassifiedWarrantMemberus-gaap:MeasurementInputExpectedTermMember2024-01-012024-09-300001795139gtbif:MultipleVotingSharesMembergtbif:ShareCapitalMember2023-12-310001795139gtbif:ContributedSurplusMember2024-07-012024-09-300001795139us-gaap:FairValueInputsLevel3Memberus-gaap:NotesReceivableMember2024-07-012024-09-300001795139gtbif:ModificationWarrantsMembergtbif:LiabilityClassifiedWarrantMember2024-09-300001795139us-gaap:BuildingImprovementsMember2024-09-300001795139us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-09-300001795139us-gaap:NotesReceivableMemberus-gaap:FairValueInputsLevel1Member2023-06-300001795139us-gaap:CommonStockMember2024-06-300001795139us-gaap:RelatedPartyMember2024-09-300001795139us-gaap:RestrictedStockUnitsRSUMember2024-09-300001795139us-gaap:FairValueInputsLevel3Member2023-09-300001795139gtbif:DharmaPharmaceuticalsLlcMember2024-01-012024-09-300001795139us-gaap:RetainedEarningsMember2023-12-310001795139us-gaap:RestrictedStockUnitsRSUMember2023-07-012023-09-300001795139gtbif:EquityClassifiedWarrantMember2023-12-310001795139us-gaap:NotesReceivableMember2023-07-012023-09-300001795139us-gaap:FairValueInputsLevel1Member2022-12-310001795139us-gaap:NoncontrollingInterestMember2024-09-300001795139us-gaap:EmployeeStockOptionMember2024-01-012024-09-300001795139us-gaap:FairValueInputsLevel1Member2024-01-012024-09-300001795139gtbif:DeferredShareIssuanceMember2022-12-310001795139srt:MinimumMembergtbif:LiabilityClassifiedWarrantMemberus-gaap:MeasurementInputExpectedTermMember2024-01-012024-09-300001795139gtbif:SubordinateVotingSharesMembergtbif:ShareCapitalMember2024-09-300001795139us-gaap:FairValueInputsLevel2Membergtbif:FinancialInstrumentsMember2024-09-300001795139us-gaap:RetainedEarningsMember2023-06-300001795139us-gaap:RestrictedStockUnitsRSUMember2024-07-012024-09-300001795139us-gaap:PendingLitigationMember2024-01-012024-09-300001795139us-gaap:LeaseholdImprovementsMember2024-09-300001795139gtbif:SuperVotingSharesMembergtbif:ShareCapitalMember2023-12-310001795139us-gaap:FairValueInputsLevel3Member2023-12-310001795139us-gaap:FairValueInputsLevel1Member2024-07-012024-09-300001795139us-gaap:TradeNamesMember2024-09-300001795139gtbif:MultipleVotingSharesMember2024-01-012024-09-300001795139us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-09-30xbrli:purexbrli:sharesgtbif:Lawsuitgtbif:Dispensaryiso4217:USDxbrli:sharesiso4217:USD

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2024

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to

img169863585_0.jpg

Commission file number 000-56132

GREEN THUMB INDUSTRIES INC.

(Exact name of registrant as specified in its charter)

British Columbia

98-1437430

(State or other jurisdiction of

incorporation or organization)

(I.R.S. employer

identification no.)

325 West Huron Street,

Suite 700 Chicago, Illinois

60654

(Address of principal executive offices)

(zip code)

Registrant’s telephone number, including area code - (312) 471-6720

Securities registered pursuant to Section 12(g) of the Act:

Subordinate Voting Shares

Multiple Voting Shares

Super Voting Shares

(Title of each Class)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No

As of November 1, 2024 there were 212,043,394 shares of the registrant’s Subordinate Voting Shares, 37,623 shares of the registrant’s Multiple Voting Shares and 206,690 shares of the registrant’s Super Voting Shares outstanding.

 

 


 

GREEN THUMB INDUSTRIES INC.

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024

TABLE OF CONTENTS

FINANCIAL

INFORMATION

Page

Part I

ITEM 1:

Unaudited Interim Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023

4

Unaudited Interim Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2024 and 2023

5

Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders’ Equity for the three and nine months ended September 30, 2024 and 2023

6

Unaudited Interim Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2024 and 2023

8

Notes to Unaudited Interim Condensed Consolidated Financial Statements

10

ITEM 2:

Management’s Discussion and Analysis of Financial Condition and Results of Operations

29

ITEM 3:

Quantitative and Qualitative Disclosure About Market Risk

37

ITEM 4:

Controls and Procedures

37

 

OTHER

INFORMATION

ITEM 1:

Legal Proceedings

38

ITEM 1A:

Risk Factors

38

ITEM 2:

Unregistered Sales of Equity Securities and Use of Proceeds

38

ITEM 3:

Defaults Upon Senior Securities

38

ITEM 4:

Mine Safety Disclosures

39

ITEM 5:

Other Information

39

ITEM 6:

Exhibits

40

Signatures

41

 

 


 

Use of Names

In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms “we,” “us,” “our,” “Company,” “Corporation” or “Green Thumb” refer to Green Thumb Industries Inc. together with its wholly-owned subsidiaries.

Currency

Unless otherwise indicated, all references to “$” or “US$” in this document refer to United States dollars, and all references to “C$” refer to Canadian dollars.

Disclosure Regarding Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains statements that we believe are, or may be considered to be, “forward-looking statements.” All statements other than statements of historical fact included in this document regarding the prospects of our industry or our prospects, plans, financial position or business strategy may constitute forward-looking statements. In addition, forward-looking statements generally can be identified by the use of forward-looking words such as “may,” “will,” “expect,” “intend,” “estimate,” “foresee,” “project,” “anticipate,” “believe,” “plan,” “forecast,” “continue” or “could” or the negative of these terms or variations of them or similar terms or expressions of similar meaning. Furthermore, forward-looking statements may be included in various filings that we make with the Securities and Exchange Commission (the “SEC”), and in press releases or oral statements made by or with the approval of one of our authorized executive officers. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we cannot assure you that these expectations will prove to be correct. These forward-looking statements are subject to certain known and unknown risks and uncertainties, as well as assumptions that could cause actual results to differ materially from those reflected in these forward-looking statements. These known and unknown risks include, without limitation: cannabis remains illegal under U.S. federal law, and enforcement of cannabis laws could change; state regulation of cannabis is uncertain; the Company may not be able to obtain or maintain necessary permits and authorizations; the Company may be subject to heightened scrutiny by Canadian regulatory authorities; the Company may face limitations on ownership of cannabis licenses; the Company may become subject to U.S. Food and Drug Administration or the U.S. Bureau of Alcohol, Tobacco Firearms and Explosives regulation; as a cannabis business, the Company is subject to applicable anti-money laundering laws and regulations and has restricted access to banking and other financial services; the Company may face difficulties acquiring additional financing; the Company lacks access to U.S. bankruptcy protections; the Company operates in a highly regulated sector and may not always succeed in complying fully with application regulatory requirements in all jurisdictions where the Company carries business; the Company faces intense competition; the Company faces competition from the illicit market as well as actual or purported Farm Bill compliant hemp products; the Company is dependent upon the popularity and consumer acceptance of its brand portfolio; the Company has limited trademark protection; cannabis businesses are subject to unfavorable tax treatment and may incur significant tax liability; the Company is subject to proceeds of crime statutes; the Company faces exposure to fraudulent or illegal activity; the Company faces risks due to industry immaturity or limited comparable, competitive or established industry best practices; the Company faces risks related to its products; the Company’s business is subject to the risks inherent in agricultural operations; the Company may adversely be impacted by rising or volatile energy costs and availability; the Company faces risks related to its information technology systems and potential cyber-attacks and security breaches; the Company relies on third-party software providers for numerous capabilities that it depends upon to operate, and a disruption of one or more systems could adversely affect the business; the Company relies on the expertise of the Company management team and other employees experienced in the cannabis industry, and the loss of key personnel could negatively affect the Company’s business, financial condition and results of operations; the Company faces an inherent risk of product liability or similar claims; the Company’s products may be subject to product recalls; the Company may face unfavorable publicity or consumer perception; and the Company’s voting control is concentrated; the Company’s capital structure and voting control may cause unpredictability; sales of substantial amounts of Subordinate Voting Shares by our shareholders in the public market may have an adverse effect on the market price of our Subordinate Voting Shares and could affect the Company’s business and financial condition and the results of operations. These and other risks are further described in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, and elsewhere in the Company’s filings with the SEC, which are available on the SEC’s website or at https://investors.gtigrows.com. Readers are cautioned not to place undue reliance on any forward-looking statements contained in this document, which reflect management’s opinions only as of the date hereof. Except as required by law, we undertake no obligation to revise or publicly release the results of any revision to any forward-looking statements. You are advised, however, to consult any additional disclosures we make in our reports to the SEC. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained in this document.

 

 

3


 

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Balance Sheets

As of September 30, 2024 and December 31, 2023

(Amounts Expressed in United States Dollars)

 

 

 

 

September 30,

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

 

 

 

(Audited)

 

 

 

(in thousands)

 

ASSETS

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

Cash and Cash Equivalents

 

$

173,641

 

 

$

161,634

 

Accounts Receivable, Net

 

 

48,962

 

 

 

42,975

 

Income Tax Receivable

 

 

5,487

 

 

 

 

Inventories, Net

 

 

138,283

 

 

 

112,970

 

Prepaid Expenses

 

 

18,164

 

 

 

19,801

 

Other Current Assets

 

 

7,337

 

 

 

5,382

 

Total Current Assets

 

 

391,874

 

 

 

342,762

 

Property and Equipment, Net

 

 

695,666

 

 

 

687,106

 

Right of Use Assets, Net

 

 

245,978

 

 

 

238,369

 

Investments

 

 

61,422

 

 

 

64,361

 

Investments in Associates

 

 

21,934

 

 

 

24,942

 

Note Receivable

 

 

3,893

 

 

 

550

 

Intangible Assets, Net

 

 

500,860

 

 

 

538,678

 

Goodwill

 

 

589,691

 

 

 

589,691

 

Deferred Tax Assets

 

 

1,041

 

 

 

1,041

 

Deposits and Other Assets

 

 

2,513

 

 

 

2,557

 

TOTAL ASSETS

 

$

2,514,872

 

 

$

2,490,057

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

Accounts Payable

 

$

19,848

 

 

$

24,495

 

Accrued Liabilities

 

 

75,584

 

 

 

59,552

 

Compensation Payable

 

 

19,295

 

 

 

16,005

 

Current Portion of Notes Payable

 

 

9,397

 

 

 

2,996

 

Current Portion of Lease Liabilities

 

 

13,329

 

 

 

12,297

 

Income Tax Payable

 

 

23,216

 

 

 

10,705

 

Total Current Liabilities

 

 

160,669

 

 

 

126,050

 

Long-Term Liabilities:

 

 

 

 

 

 

Lease Liabilities, Net of Current Portion

 

 

260,790

 

 

 

249,464

 

Notes Payable, Net of Current Portion and Debt Discount

 

 

246,182

 

 

 

305,527

 

Contingent Consideration Payable

 

 

 

 

 

33,250

 

Deferred Income Taxes

 

 

72,510

 

 

 

72,510

 

TOTAL LIABILITIES

 

 

740,151

 

 

 

786,801

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

SHAREHOLDERS' EQUITY

 

 

 

 

 

 

Subordinate Voting Shares (Shares Authorized, Issued and Outstanding at September 30, 2024:
   
Unlimited, 211,718,705, and 211,718,705, respectively, at December 31, 2023:
   
Unlimited, 209,871,792, and 209,871,792, respectively)

 

 

 

 

 

 

Multiple Voting Shares (Shares Authorized, Issued and Outstanding at September 30, 2024:
   
Unlimited, 37,683 and 37,683, respectively, at December 31, 2023:
   
Unlimited, 38,531 and 38,531, respectively)

 

 

 

 

 

 

Super Voting Shares (Shares Authorized, Issued and Outstanding at September 30, 2024:
   
Unlimited, 206,690 and 206,690, respectively, at December 31, 2023:
   
Unlimited, 216,690 and 216,690, respectively)

 

 

 

 

 

 

Share Capital

 

 

1,748,788

 

 

 

1,703,852

 

Contributed (Deficit) Surplus

 

 

(25,520

)

 

 

7,871

 

Deferred Share Issuances

 

 

12,973

 

 

 

12,973

 

Accumulated Earnings (Deficit)

 

 

38,586

 

 

 

(21,818

)

Equity of Green Thumb Industries Inc.

 

 

1,774,827

 

 

 

1,702,878

 

Noncontrolling interests

 

 

(106

)

 

 

378

 

TOTAL SHAREHOLDERS' EQUITY

 

 

1,774,721

 

 

 

1,703,256

 

TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

 

$

2,514,872

 

 

$

2,490,057

 

 

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

4


 

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Statements of Operations

Three and Nine Months Ended September 30, 2024 and 2023

(Amounts Expressed in United States Dollars, Except Share Amounts)

 

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

2024

 

2023

 

 

2024

 

2023

 

 

(in thousands)

 

 

(in thousands)

Revenues, Net of Discounts

$

286,865

$

275,398

 

$

842,818

$

776,322

Cost of Goods Sold

 

(139,274)

 

(141,592)

 

 

(399,778)

 

(392,515)

Gross Profit

 

147,591

 

133,806

 

 

443,040

 

383,807

Expenses:

 

 

 

 

 

 

 

 

 

Selling, General, and Administrative

 

104,967

 

84,779

 

 

275,725

 

249,515

Total Expenses

 

104,967

 

84,779

 

 

275,725

 

249,515

Income From Operations

 

42,624

 

49,027

 

 

167,315

 

134,292

Other Income (Expense):

 

 

 

 

 

 

 

 

 

Other (Expense) Income, Net

 

(290)

 

(631)

 

 

411

 

23

Interest Income, Net

 

2,665

 

1,576

 

 

7,082

 

4,838

Interest Expense, Net

 

(5,296)

 

(4,639)

 

 

(18,791)

 

(11,324)

Total Other Expense

 

(2,921)

 

(3,694)

 

 

(11,298)

 

(6,463)

Income Before Provision for Income Taxes And Non-Controlling Interest

 

39,703

 

45,333

 

 

156,017

 

127,829

Provision For Income Taxes

 

30,922

 

34,526

 

 

94,970

 

93,927

Net Income Before Non-Controlling Interest

 

8,781

 

10,807

 

 

61,047

 

33,902

Net Income Attributable to Non-Controlling Interest

 

165

 

295

 

 

643

 

851

Net Income Attributable To Green Thumb Industries Inc.

$

8,616

$

10,512

 

$

60,404

$

33,051

Net Income Per Share - Basic

$

0.04

$

0.05

 

$

0.26

$

0.14

Net Income Per Share - Diluted

$

0.04

$

0.05

 

$

0.26

$

0.14

Weighted Average Number of Shares Outstanding - Basic

 

236,303,348

 

239,459,783

 

 

236,821,181

 

238,248,852

Weighted average Number of Shares Outstanding - Diluted

 

238,295,887

 

240,289,959

 

 

239,934,521

 

239,827,112

 

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

5


 

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders’ Equity

Three and Nine Months Ended September 30, 2024 and 2023

(Amounts Expressed in United States Dollars)

 

 

 

 

Share
Capital

 

 

Contributed
Surplus (Deficit)

 

 

Deferred Share
Issuance

 

 

Accumulated
Earnings (Deficit)

 

 

Non-Controlling
Interest

 

 

Total

 

 

 

(in thousands)

 

Balance, July 1, 2023

$

 

1,693,429

 

$

 

34,421

 

$

 

12,973

 

$

 

(35,546

)

$

 

539

 

$

 

1,705,816

 

Distribution of contingent consideration

 

 

6,454

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6,454

 

Exercise of options, RSUs

 

 

2,461

 

 

 

(694

)

 

 

 

 

 

 

 

 

 

 

 

1,767

 

Stock-based compensation

 

 

 

 

 

7,215

 

 

 

 

 

 

 

 

 

 

 

 

7,215

 

Distributions to non-controlling interest holders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(270

)

 

 

(270

)

Repurchase of Subordinate Voting Shares

 

 

 

 

 

(24,890

)

 

 

 

 

 

 

 

 

 

 

 

(24,890

)

Net income

 

 

 

 

 

 

 

 

 

 

 

10,512

 

 

 

295

 

 

 

10,807

 

Balance, September 30, 2023

$

 

1,702,344

 

$

 

16,052

 

$

 

12,973

 

$

 

(25,034

)

$

 

564

 

$

 

1,706,899

 

Balance, January 1, 2023

$

 

1,663,557

 

$

 

23,233

 

$

 

36,211

 

$

 

(58,085

)

$

 

516

 

$

 

1,665,432

 

Issuance of deferred shares

 

 

20,454

 

 

 

 

 

 

(20,454

)

 

 

 

 

 

 

 

 

 

Distribution of contingent consideration

 

 

12,524

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12,524

 

Indemnification of deferred shares associated with post acquisition costs

 

 

 

 

 

 

 

 

(2,784

)

 

 

 

 

 

 

 

 

(2,784

)

Exercise of options and RSUs

 

 

5,809

 

 

 

(3,126

)

 

 

 

 

 

 

 

 

 

 

 

2,683

 

Stock-based compensation

 

 

 

 

 

20,835

 

 

 

 

 

 

 

 

 

 

 

 

20,835

 

Distributions to non-controlling interest holders

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(803

)

 

 

(803

)

Repurchase of Subordinate Voting Shares

 

 

 

 

 

(24,890

)

 

 

 

 

 

 

 

 

 

 

 

(24,890

)

Net income

 

 

 

 

 

 

 

 

 

 

 

33,051

 

 

 

851

 

 

 

33,902

 

Balance, September 30, 2023

$

 

1,702,344

 

$

 

16,052

 

$

 

12,973

 

$

 

(25,034

)

$

 

564

 

$

 

1,706,899

 

 

 

 

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6


 

 

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Statements of Changes in Shareholders’ Equity

Three and Nine Months Ended September 30, 2024 and 2023

(Amounts Expressed in United States Dollars)

 

 

 

 

Share
Capital

 

Contributed
Surplus (Deficit)

 

Deferred Share
Issuance

 

Accumulated
Earnings (Deficit)

 

Non-Controlling
Interest

 

Total

 

 

(in thousands)

Balance, July 1, 2024

$

1,742,784

$

(31,865)

$

12,973

$

29,970

$

94

$

1,753,956

Exercise of options and RSUs

 

6,028

 

(2,004)

 

 

 

 

4,024

Options exercised through net share settlement

 

(24)

 

 

 

 

 

(24)

Stock-based compensation

 

 

8,349

 

 

 

 

8,349

Distributions to non-controlling interest holders

 

 

 

 

 

(365)

 

(365)

Net income

 

 

 

 

8,616

 

165

 

8,781

Balance, September 30, 2024

$

1,748,788

$

(25,520)

$

12,973

$

38,586

$

(106)

$

1,774,721

Balance, January 1, 2024

$

1,703,852

$

7,871

$

12,973

$

(21,818)

$

378

$

1,703,256

Distribution of contingent consideration

 

17,259

 

 

 

 

 

17,259

Exercise of options and RSUs

 

16,818

 

(6,856)

 

 

 

 

9,962

Options exercised through net share settlement

 

10,859

 

(16,792)

 

 

 

 

(5,933)

Stock-based compensation

 

 

23,705

 

 

 

 

23,705

Distributions to non-controlling interest holders

 

 

 

 

 

(1,127)

 

(1,127)

Repurchase of Subordinate Voting Shares

 

 

(33,448)

 

 

 

 

(33,448)

Net income

 

 

 

 

60,404

 

643

 

61,047

Balance, September 30, 2024

$

1,748,788

$

(25,520)

$

12,973

$

38,586

$

(106)

$

1,774,721

 

 

 

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

7


 

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Statements of Cash Flows

Nine Months Ended September 30, 2024 and 2023

(Amounts Expressed in United States Dollars)

 

 

 

 

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

CASH FLOW FROM OPERATING ACTIVITIES

 

 

 

 

 

 

Net income attributable to Green Thumb Industries Inc.

 

$

60,404

 

 

$

33,051

 

Net income attributable to non-controlling interest

 

 

643

 

 

 

851

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

84,252

 

 

 

73,363

 

Amortization of operating lease right of use assets

 

 

41,622

 

 

 

35,996

 

Loss on disposal of property and equipment

 

 

1,163

 

 

 

2,815

 

Impairment of long-lived property and equipment

 

 

450

 

 

 

285

 

Loss on equity method investments

 

 

2,184

 

 

 

952

 

Loss from lease modification

 

 

219

 

 

 

87

 

Stock-based compensation

 

 

23,705

 

 

 

20,835

 

(Increase) decrease in fair value of investments

 

 

(256

)

 

 

153

 

Gain on settlement of contingent consideration

 

 

(15,991

)

 

 

 

Increase in fair value of contingent consideration

 

 

 

 

 

3,370

 

Decrease in fair value of warrants

 

 

(2,389

)

 

 

(934

)

Gain on indemnification of deferred shares associated with post acquisition costs

 

 

 

 

 

(2,784

)

Amortization of debt discount

 

 

2,914

 

 

 

7,128

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

Accounts receivable, net

 

 

(5,987

)

 

 

(7,673

)

Inventories, net

 

 

(25,313

)

 

 

(2,870

)

Prepaid expenses and other current assets

 

 

1,391

 

 

 

(1,129

)

Deposits and other assets

 

 

44

 

 

 

536

 

Accounts payable

 

 

(4,647

)

 

 

4,084

 

Accrued liabilities

 

 

17,504

 

 

 

4,052

 

Operating lease liabilities

 

 

(37,091

)

 

 

(32,114

)

Income tax receivable and payable, net

 

 

7,024

 

 

 

13,818

 

NET CASH PROVIDED BY OPERATING ACTIVITIES

 

 

151,845

 

 

 

153,872

 

CASH FLOW FROM INVESTING ACTIVITIES

 

 

 

 

 

 

Purchases of property and equipment

 

 

(52,992

)

 

 

(183,594

)

Proceeds from disposal of property and equipment

 

 

345

 

 

 

319

 

Investments in securities and associates

 

 

(7,803

)

 

 

(4,500

)

Proceeds from equity investments and notes receivable

 

 

7,015

 

 

 

331

 

NET CASH USED IN INVESTING ACTIVITIES

 

 

(53,435

)

 

 

(187,444

)

CASH FLOW FROM FINANCING ACTIVITIES

 

 

 

 

 

 

Distributions to non-controlling interest holders

 

 

(1,127

)

 

 

(803

)

Repurchase of Subordinate Voting Shares

 

 

(33,448

)

 

 

(24,890

)

Payments for taxes related to net share settlement of equity awards

 

 

(5,933

)

 

 

 

Proceeds from exercise of options and RSUs

 

 

9,962

 

 

 

2,683

 

Proceeds from issuance of notes payable

 

 

170,923

 

 

 

16,654

 

Principal repayment of notes payable

 

 

(226,780

)

 

 

(912

)

NET CASH USED IN FINANCING ACTIVITIES

 

 

(86,403

)

 

 

(7,268

)

CASH AND CASH EQUIVALENTS:

 

 

 

 

 

 

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

 

 

12,007

 

 

 

(40,840

)

CASH AND CASH EQUIVALENTS BEGINNING OF PERIOD

 

 

161,634

 

 

 

177,682

 

CASH AND CASH EQUIVALENTS END OF PERIOD

 

$

173,641

 

 

$

136,842

 

 

 

 

 

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

 

 

 

 

 

 

 

 

 

 

 

 

 

 

8


 

 

Green Thumb Industries Inc.

Unaudited Interim Condensed Consolidated Statements of Cash Flows

Nine Months Ended September 30, 2024 and 2023

(Amounts Expressed in United States Dollars)

 

 

Nine Months Ended September 30,

 

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

 

 

 

 

 

 

Interest paid

 

$

16,555

 

 

$

15,564

 

NONCASH INVESTING AND FINANCING ACTIVITIES

 

 

 

 

 

 

Accrued capital expenditures

 

$

3,958

 

 

$

(10,115

)

Noncash increase in right of use asset

 

$

(11,937

)

 

$

(5,599

)

Noncash increase in lease liability

 

$

11,937

 

 

$

5,599

 

Issuance of shares associated with contingent consideration

 

$

17,259

 

 

$

12,524

 

Deferred share distributions

 

$

 

 

$

(20,454

)

 

The accompanying notes are an integral part of these unaudited interim condensed consolidated financial statements

9


Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

1. Overview and Basis of Presentation

 

 

(a) Description of Business

Green Thumb Industries Inc. (“Green Thumb,” the “Company,” “we” or “us”), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while being committed to community and sustainable, profitable growth. Green Thumb owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM, to third-party retail stores across the United States as well as to Green Thumb owned retail locations. The Company also owns and operates retail cannabis stores that include a national chain named RISE Dispensaries that sell our products and third-party products. As of September 30, 2024, Green Thumb has revenue in fourteen markets (California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia), employs approximately 4,800 people and serves millions of patients and customers annually.

The Company’s registered office is located at 250 Howe Street, 20th Floor, Vancouver, British Columbia, V6C 3R8. The Company’s U.S. headquarters are at 325 W. Huron St., Suite 700, Chicago, IL 60654.

 

(b) Basis of Presentation

The accompanying unaudited interim condensed consolidated financial statements include the accounts of Green Thumb and have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and in accordance with the rules and regulations of the U.S. Securities & Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements and, accordingly, certain information, footnotes and disclosures normally included in the annual financial statements, prepared in accordance with GAAP, have been condensed or omitted in accordance with SEC rules and regulations. The financial data presented herein should be read in conjunction with the audited consolidated financial statements and accompanying notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”). In the opinion of management, the financial data presented includes all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented. Certain previously reported amounts have been reclassified between line items to conform to the current period presentation. Results of interim periods should not be considered indicative of the results for the full year. These unaudited interim condensed consolidated financial statements include estimates and assumptions of management that affect the amounts reported in the unaudited condensed consolidated financial statements. Actual results could differ from these estimates.

 

(c) Significant Accounting Policies

There have been no changes to the Company’s significant accounting policies as described in Note 2 to the Company's Consolidated Financial Statements included in the 2023 Form 10-K.

 

(d) Earnings per Share

Basic earnings per share is calculated using the treasury stock method, by dividing the net earnings attributable to shareholders by the weighted average number of common shares outstanding during each of the periods presented. Contingently issuable shares (including shares held in escrow) are not considered outstanding common shares and consequently are not included in the earnings per share calculation. Diluted earnings per share is calculated using the treasury stock method by adjusting the weighted average number of common shares outstanding to assume conversion of all dilutive potential common shares. The Company has three categories of potentially dilutive common share equivalents: restricted stock units, stock options and warrants. As of September 30, 2024, the Company had 8,491,983 options, 4,561,819 restricted stock units and 2,128,022 warrants outstanding. As of September 30, 2023, the Company had 10,229,895 options, 3,499,193 restricted stock units and 3,734,555 warrants outstanding.

10


Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

1. Overview and Basis of Presentation (Continued)

 

(d) Earnings per Share (Continued)

In order to determine diluted earnings per share, it is assumed that any proceeds from the vesting of dilutive unvested restricted stock units, or exercise of unvested stock options and warrants would be used to repurchase common shares at the average market price during the period. Under the treasury stock method, the diluted earnings per share calculation excludes any potential conversion of stock options and convertible debt that would increase earnings per share or decrease loss per share. For the three months ended September 30, 2024, the computation of diluted earnings per share included 1,001,228 options, 923,686 restricted stock units, and 67,625 warrants. For the nine months ended September 30, 2024, the computation of diluted earnings per share included 1,339,591 options, 1,669,708 restricted stock units, and 104,041 warrants. For the three months ended September 30, 2023, the computation of diluted earnings per share included 211,651 options and 618,525 restricted stock units. For the nine months ended September 30, 2023, the computation of diluted earnings per share included 153,215 options and 1,425,045 restricted stock units. There were no dilutive warrants during the three and nine months ended September 30, 2023 as the strike price was greater than the average stock price for the period. For the three and nine months ended September 30, 2024, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 869,491 and 918,465, respectively. For the three and nine months ended September 30, 2023, the weighted average number of anti-dilutive stock options excluded from the computation of diluted earnings per share were 2,349,064 and 3,198,625, respectively.

 

(e) Recently Issued Accounting Standards

(i)
In November 2023, the FASB issued Accounting Standards Update (ASU”) No. 2023-07, Segment Reporting (Topic 280) - Improvements to Reportable Segment Disclosures, to provide enhanced segment disclosures. The standard will require disclosures about significant segment expense categories and amounts for each reportable segment, for all periods presented. Additionally, the standard requires public entities to disclose the title and position of the Chief Operating Decision Maker (CODM”) in the consolidated financial statements. These enhanced disclosures are required for all entities on an interim and annual basis, effective for fiscal years beginning after December 15, 2023, and interim periods within annual periods beginning after December 15, 2024. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements.
(ii)
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which is intended to provide enhancements to annual income tax disclosures. The standard will require more detailed information in the rate reconciliation table and for income taxes paid, among other enhancements. The standard is effective for years beginning after December 15, 2024 and early adoption is permitted. The adoption of this standard is not expected to have a material impact on the Company’s consolidated financial statements.

The Company reviews recently issued accounting standards on a quarterly basis and has determined there are no other standards yet to be adopted which are relevant to the business for disclosure.

11


Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

2. INVENTORIES

 

 

The Company’s inventories include the following at September 30, 2024 and December 31, 2023:

 

 

September 30, 2024

 

December 31, 2023

 

 

(in thousands)

Raw Material

$

2,961

$

1,547

Packaging and Miscellaneous

 

11,806

 

10,661

Work in Process

 

54,764

 

47,029

Finished Goods

 

72,566

 

57,631

Reserve for Obsolete Inventory

 

(3,814)

 

(3,898)

Total Inventories, Net

$

138,283

$

112,970

 

3. PROPERTY AND EQUIPMENT

 

 

At September 30, 2024 and December 31, 2023, property and equipment consisted of the following:

 

 

 

September 30, 2024

 

December 31, 2023

 

 

(in thousands)

Buildings and Improvements

$

354,054

$

353,912

Equipment, Computers and Furniture

 

189,736

 

171,522

Leasehold Improvements

 

229,964

 

200,232

Land

 

33,725

 

33,725

Land Improvements

 

1,538

 

1,046

Assets Under Construction

 

27,388

 

23,142

Capitalized Interest

 

31,944

 

30,817

Total Property and Equipment

 

868,349

 

814,396

Less: Accumulated Depreciation

 

(172,683)

 

(127,290)

Property and Equipment, net

$

695,666

$

687,106

 

Assets under construction represent costs associated with construction projects on cultivation and production facilities and retail stores as well as costs associated with internal-use software not yet placed in service.

Depreciation expense for the three and nine months ended September 30, 2024 totaled $15,918 thousand and $46,434 thousand, respectively, of which $10,240 thousand and $29,963 thousand, respectively, is included in cost of goods sold. Depreciation expense for the three and nine months ended September 30, 2023 totaled $12,885 thousand and $35,266 thousand, respectively, of which $8,298 thousand and $23,348 thousand, respectively, is included in cost of goods sold.

 

12


Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

4. INTANGIBLE ASSETS AND GOODWILL

 

 

(a) Intangible Assets

Intangible assets are recorded at cost less accumulated amortization and impairment losses. Intangible assets acquired in a business combination are measured at fair value at the acquisition date. Amortization of definite life intangibles is provided on a straight-line basis over their estimated useful lives. The estimated useful lives, residual values, and amortization methods are reviewed at each year end, and any changes in estimates are accounted for prospectively.

At September 30, 2024 and December 31, 2023, intangible assets consisted of the following:

 

 

 

September 30, 2024

 

December 31, 2023

 

 

Gross Carrying Amount

 

Accumulated Amortization

 

Net Book Value

 

Gross Carrying Amount

 

Accumulated Amortization

 

Net Book Value

 

 

(in thousands)

 

(in thousands)

Licenses and Permits

$

660,716

$

190,838

$

469,878

$

660,716

$

157,764

$

502,952

Trademarks

 

41,511

 

15,422

 

26,089

 

41,511

 

13,378

 

28,133

Customer Relationships

 

24,438

 

19,545

 

4,893

 

24,438

 

16,927

 

7,511

Non-Competition Agreements

 

2,565

 

2,565

 

 

2,565

 

2,483

 

82

Total Intangible Assets

$

729,230

$

228,370

$

500,860

$

729,230

$

190,552

$

538,678

The Company recorded amortization expense for the three and nine months ended September 30, 2024 of $12,574 thousand and $37,818 thousand, respectively. The Company recorded amortization expense for the three and nine months ended September 30, 2023 of $12,743 thousand and $38,097 thousand, respectively. As of September 30, 2024 and December 31, 2023, intangible assets are carried net of accumulated impairment losses of $31,131 thousand as of each period then ended.

The following table outlines the estimated annual amortization expense related to intangible assets as of September 30, 2024:

 

 

Estimated
Amortization

Year Ending December 31,

 

(in thousands)

Remainder of 2024

$

12,574

2025

 

50,294

2026

 

47,332

2027

 

46,803

2028

 

46,803

2029 and Thereafter

 

297,054

 

$

500,860

As of September 30, 2024, the weighted average amortization period remaining for intangible assets was 10.68 years.

(b) Goodwill

At September 30, 2024 and December 31, 2023 the balances of goodwill, by segment, consisted of the following:

 

 

 

September 30, 2024

 

December 31, 2023

 

 

(in thousands)

Retail

$

273,802

$

273,802

Consumer Packaged Goods

 

315,889

 

315,889

Total

$

589,691

$

589,691

 

Goodwill is recognized net of accumulated impairment losses of $57,372 thousand as of September 30, 2024 and December 31, 2023. During the three and nine months ended September 30, 2024 and 2023, there were no goodwill impairment charges recognized by the Company in the unaudited interim condensed consolidated statements of operations.

 

13


14Green Thumb Industries Inc.

Notes to Unaudited Interim Condensed Consolidated Financial Statements

(Amounts Expressed in United States Dollars, Except Where Stated Otherwise)

 

5. INVESTMENTS

 

 

As of September 30, 2024 and December 31, 2023, the Company held various equity interests in cannabis-related companies as well as investments in note(s) receivable instruments that had a combined fair value of $61,422 thousand and $64,361 thousand, respectively. The Company measures its investments that do not have readily determinable fair value at cost minus impairment, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The Company performs an assessment on a quarterly basis to determine whether triggering events for impairment exist and to identify any observable price changes.

The following table summarizes the changes in the Company’s investments during the nine months ended September 30, 2024 and year ended December 31, 2023:

 

 

 

September 30, 2024

 

December 31, 2023

 

 

(in thousands)

Beginning

$

64,361

$

74,169

Additions

 

3,817

 

8,200

Proceeds

 

(7,012)

 

(498)

Fair value adjustment

 

256

 

(17,460)

Transfers and other

 

 

(50)

Ending

$

61,422

$

64,361

 

The following table summarizes the change in fair value associated with the Company's equity investments and notes receivable instruments recorded during the three and nine months ended September 30, 2024 and 2023.

 

 

Three Months Ended September 30,